The role of APE1/REF-1 redox activity inhibitor APX2009 in BC cells is still unknown; thus, we investigated its effect on the malignant phenotype using the BC cells MDA-MB-231 and MCF-7 as models. This evidence concerns the gene APEX1 and breast cancer.